Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4218019
Max Phase: Preclinical
Molecular Formula: C46H47F3N6O9S2
Molecular Weight: 949.04
Molecule Type: Small molecule
Associated Items:
ID: ALA4218019
Max Phase: Preclinical
Molecular Formula: C46H47F3N6O9S2
Molecular Weight: 949.04
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(/C=C2\SC(=O)N(CCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)C2=O)ccc1Oc1ccc(C#N)cc1C(F)(F)F
Standard InChI: InChI=1S/C46H47F3N6O9S2/c1-26-39(65-25-52-26)30-10-6-27(7-11-30)23-51-41(58)33-21-31(56)24-55(33)43(60)40(45(2,3)4)53-38(57)14-16-63-17-15-54-42(59)37(66-44(54)61)20-28-8-13-35(36(19-28)62-5)64-34-12-9-29(22-50)18-32(34)46(47,48)49/h6-13,18-20,25,31,33,40,56H,14-17,21,23-24H2,1-5H3,(H,51,58)(H,53,57)/b37-20-/t31-,33+,40-/m1/s1
Standard InChI Key: IIJORMBEWMYDEN-FRKKMCEPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 949.04 | Molecular Weight (Monoisotopic): 948.2798 | AlogP: 7.06 | #Rotatable Bonds: 16 |
Polar Surface Area: 200.49 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.25 | CX Basic pKa: 2.65 | CX LogP: 4.71 | CX LogD: 4.71 |
Aromatic Rings: 4 | Heavy Atoms: 66 | QED Weighted: 0.08 | Np Likeness Score: -1.08 |
1. (2016) 7 (12): [10.1039/C6MD00347H] |
2. Peng L, Zhang Z, Lei C, Li S, Zhang Z, Ren X, Chang Y, Zhang Y, Xu Y, Ding K.. (2019) Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation., 10 (5): [PMID:31097997] [10.1021/acsmedchemlett.9b00025] |
3. Edmondson SD, Yang B, Fallan C.. (2019) Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges., 29 (13): [PMID:31047748] [10.1016/j.bmcl.2019.04.030] |
4. Hu B, Zhou Y, Sun D, Yang Y, Liu Y, Li X, Li H, Chen L.. (2020) PROTACs: New method to degrade transcription regulating proteins., 207 [PMID:32858471] [10.1016/j.ejmech.2020.112698] |
Source(1):